Skip to main content
Skip to footer

India Pharma Award 2022

Features

Improved data quality and oversight

Quicker decision-making

Meaningful insights and preventive intervention

Faster drug registration process

Challenge

Pharma organizations need to enable informed, engaged, and connected clinical trials that are patient-centric and site-friendly.

The siloed, convoluted, and cumbersome clinical trial processes levied immense operational burden on sites, sponsors, and CROs, thus preventing them from executing trials effectively. Disparate systems have resulted in manual, paper-based, time consuming, and error-prone processes resulting in delayed trial timeline.

TCS ADD Connected Clinical Trials provides a unified interface for patients and sites and incorporates smart, intuitive, futuristic, cloud-based technologies and collaborations to enable next-generation patient-centric trials. 

14+ Patents | 19+ Global customers | 700+ Trials supported | 50K+ Sites onboarded | 100% Regulatory compliant | 

Enabling a time-critical remote consent

TCS helped Roche roll out an eConsent solution

 

Our Offerings

An industry-first unified platform for clinical supply management that brings together kit tracking, unit dose tracking, and digital labels supporting direct-to-patient and traditional supply models.

Highly configurable solution with a rich library of personalized and multimedia engagement tools

Secure, end-to-end consent solution supporting paper-based and e-signature; embedded with multimedia engagement tools 

Device-agnostic, seamless, multi-tenant, and feature-rich televisit functionality for patients, sites, and sponsors

Biometric sensors with connected medical devices for timely and accurate health insights through automated data collection and remote monitoring

Personalized patient and site support throughout the trial process via portals, apps, and multimedia literature

  • Rich library of multimedia content available in more than 20 languages
  • AI-driven automated ethics submission package creation and verification
  • Proprietary patient and site app. BYOD configurations  
  • Real-time actionable alerts supported by smart wearable devices and gadgets, smart blisters, bottles, etc. 
  • Multiple consenting modes – remote, traditional, hybrid, with wet signatures or paper signed 
  • Easy integration with native systems and quick deployment
Modern technologies, deep contextual expertise and, close collaboration with pharma organizations, patient advocacy groups, regulatory bodies, clinicians and others alike combined with an ability to support adaptive (virtual, traditional, and hybrid) studies make TCS ADD Connected Clinical Trials, our decentralized trials platform, a preferred choice for trials worldwide.
Rachna Malik

Global Head, TCS ADD Platforms

RECOGNITION

TCS ADD wins the 2021 India Pharma award

TCS ADD wins the 2021 India Pharma award

TCS ADD Safety wins the 2020-21 Awards.AI for using AI to re-imagine pharmacovigilance

TCS ADD Safety wins the 2020-21 Awards.AI for using AI to re-imagine pharmacovigilance

TCS ADD Connected Clinical Trials platform wins the 2020 Citeline Award

TCS ADD Connected Clinical Trials platform wins the 2020 Citeline Award

TCS' ADD Connected Clinical Trials platform wins the European Innovations Award

TCS' ADD Connected Clinical Trials platform wins the European Innovations Award

contact-icon Contact us Contact us